Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reticuloendothelial System Macrophage (RES-macrophage)
- Target
- RES-macrophage
- Molecular classification
- Cell, Phagocyte, Immune cell
01
Overview
The reticuloendothelial system (RES), now more commonly referred to as the mononuclear phagocyte system (MPS), is a network of cells primarily involved in the clearance of foreign particles, cellular debris, and pathogens from the bloodstream and tissues. The key effector cells within this system are macrophages, which originate from blood monocytes that migrate into tissues and differentiate. They perform crucial roles in phagocytosis, antigen presentation, immune regulation, cytotoxicity, iron recycling, and tissue homeostasis.
- Other names
- Tissue-resident macrophageMPS-macrophageMononuclear phagocyte system macrophageKupffer cellsSinus histiocytesAlveolar macrophages (dust cells)MicrogliaRed pulp macrophagesPeritoneal macrophagesOsteoclastsLangerhans cellsEpithelioid histiocytesHofbauer cellsMesangial cells
02
Mechanism of action
Varies depending on the drug and macrophage function; can include modulation of cytokine secretion, phagocytosis, antigen presentation, or direct cytotoxicity.
03
Biological functions
PhagocytosisAntigen presentationImmune regulationCytotoxicityIron storage & recyclingTissue homeostasis & repairWound healing
04
Disease associations
InfectionInflammationCancerAutoimmune diseasesTissue damageSepsisShockBiliary obstructionTrauma recoveryAtherosclerosisNeurodegenerative diseases
05
Safety considerations
Excessive inflammationCytokine stormImpaired wound healingOpportunistic infections (with immunosuppression)Contribution to fibrosisTumor promotion in certain contexts
06
Interacting drugs
Cytokines (various)
5 more in the full profile.
07
Biomarkers
Macrophage-related cytokines (e.g., TNF-alpha, IL-1, IL-6, IL-10)Macrophage surface markers (e.g., CD68, CD163)Phagocytic capacity assaysMarkers of inflammation (e.g., CRP, ESR)
Beyond the preview
Go deeper on Reticuloendothelial System Macrophage (RES-macrophage).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Reticuloendothelial System Macrophage (RES-macrophage).